Sperm Preparation
Sperm Preparation
LAB&&100
Lesson 7
References ...................................................................................................................................... 26
These materials are copyrighted by the American Society for Reproductive Medicine. They are intended
for personal use and may not be reproduced or distributed without permission.
Course Overview
ACTIVITY TITLE: Preparation and Selection of Sperm for IVF and ICSI
ACCREDITATION STATEMENT
The American Society for Reproductive Medicine is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Reproductive Medicine has been approved to provide Professional Enrichment
Education Renewal (PEER) credit through the American Board of Bioanalysis. Credits are pending for
this activity.
This presentation provides an overview of the sperm preparation techniques, including conventional
preparation procedures, nutrient media, and supplements as they relate to the insemination technique.
Procedures for handling testicular biopsy specimens and epididymal aspirates, as well as special sperm
selection techniques will be discussed. This information is useful for clinicians, laboratory scientists,
embryologists and andrologists who will be involved directly or indirectly in the evaluation of the male
partner of the ART couple, and the preparation of sperm for use in ART cycles. The educational need for
this activity was based on the 2014 gap analysis review by the ASRM CME Committee.
EDUCATIONAL OBJECTIVES
At the conclusion of this educational activity, participants should be able to:
1. Discuss the goals of any sperm preparation technique to obtain sufficient viable sperm for
insemination of retrieved oocytes.
2. Discuss the laboratory methodology for sperm preparation for assisted reproduction, including
1
media and supplements, swim-up and density gradients, testicular and epididymal sperm, and fresh
versus frozen sperm.
3. Discuss special techniques for sperm preparation including use of hypoosmotic buffer, hyaluronan
binding, calcium ionophore, and intracytoplasmic morphologically selected sperm injection
(IMSI)/motile sperm organelle morphology examination (MSOME) procedures.
TARGET AUDIENCE
This activity is designed to meet the educational needs of new and experienced laboratory scientists and
allied health professionals involved in assisted reproduction.
ACGME COMPETENCIES
Medical Knowledge
Patient Care
Planners
Susan A. Gitlin, PhD: Nothing to Disclose
Michael Reed, PhD: Nothing to Disclose
Andrew R. La Barbera, PhD: Nothing to Disclose
Richard H. Reindollar, MD: Nothing to Disclose
Nancy Bowers, BSN, RN, MPH: Nothing to Disclose
2
Carli Chapman, MS: Nothing to Disclose Z. Peter Nagy, MD, PhD: Direct stockholder: My Egg
Ri-Cheng Chian, PhD: Other: Cooper Surgical/SAGE Bank; Paid consultant: Origio, Fertilitech; Speakers
Company bureau: Merck MSD
Susan Crockin, JD: Consultant: BMS, Merck, Mike Neal, MSc: Nothing to Disclose
Prometheus; Advisory Board: GSK, CoStim, Aveo; Fariba Nehchiri, MSc: Nothing to Disclose
Speakers Bureau: Pfizer Canada, BMS Sergio Oehninger, PhD: Nothing to Disclose
Judith Daar, JD: Nothing to Disclose Kimball Pomeroy, PhD: Nothing to Disclose
Erma Drobnis, PhD: Nothing to Disclose Thomas (Rusty) Pool, PhD: Other: Auxogyn
Kathryn Go, PhD: Nothing to Disclose Marc Portmann, MHA, MT: Nothing to Disclose
Kay Graff, MS: Consultant: Steptoe Therapeutics; Catherine Racowsky, PhD: Consultant: Nora
Employee: Pelton & Crane Therapeutics
Elizabeth Grill, PsyD: SouthEastern Fertility: Speakers Lisa Rinehart, JD: Nothing to Disclose
Bureau William Roudebush, PhD: Nothing to Disclose
Shalini Gunawardena, RN, BSN: Walgreen's Nursing Denny Sakkas, PhD: Consultant: Good Start Genetics;
Advisory Board Other: Fertilitech, Origio
Lee Higdon, PhD: Nothing to Disclose Mitchel Schiewe, PhD: Nothing to Disclose
Kristen Ivani, PhD: Nothing to Disclose Ira Sharlip, MD: Consultant: Pfizer, Lilly, Absorption,
Sangita Jindal, PhD: Nothing to Disclose Vyrix
Emily Jungheim, MD: Spouse is paid consultant: Scott Smith, PhD: Product Review: Biocoat
Abbvie, Genentech, Spectrum, Celgene; Speakers Amy Sparks, PhD: Nothing to Disclose
bureau: Genentech Laurel Stadtmauer, MD: Nothing to Disclose
Levent Keskintepe, DVM, PhD: Nothing to Disclose Jason Swain, PhD: Consultant: Irvine Scientific
Ann Kiessling, PhD: Nothing to Disclose Tyl Taylor, MSc: Consultant; Spouse employed:
Rebecca Krisher, PhD: Grant/Research: Serono Biodiseño
Martin Langley, BS: Nothing to Disclose Helen Tempest, PhD: Nothing to Disclose
Michael Lee, MS: Consultant: Cook Medical James Toner, MD, PhD: Speakers bureau: Merck
Bruce Lessey, MD, PhD: Nothing to Disclose Nathan Treff, PhD: Nothing to Disclose
Dennis Matt, PhD: Nothing to Disclose Tom Turner, MS: Nothing to Disclose
David McCulloh, PhD: Consultant: Infertility and IVF Matthew VerMilyea, PhD: Consultant: Auxogyn, Irvine
Medical Associates of Western NY; ReproART; Scientific, Genea Biomedx
Biogenetics Corporation; Employee: NYU Langone Michael Vernon, PhD: Nothing to Disclose
Medical Center Diane Wright, PhD: Nothing to Disclose
Peter McGovern, MD: Nothing to Disclose Hang Yin, PhD: Nothing to Disclose
Yves Menezo, DSc, PhD: Consultant: Nurilia
It is the policy of the ASRM to ensure balance, independence, objectivity, and scientific rigor in all its
educational activities. All faculty/authors participating in this activity were required to disclose any
relationships they may have with commercial entities whose products or services are used to treat
patients so that participants may evaluate the objectivity of the presentations. The content and views
presented in this activity are those of the faculty/authors and do not necessarily reflect those of the
ASRM. Any discussion of off-label, experimental, or investigational use of drugs or devices will also be
disclosed. The disclosure statements were reviewed by the Subcommittee for Standards of Commercial
Support of the CME Committee of ASRM and any perceived conflicts of interest were resolved in
accordance with the policies of the ACCME.
STATEMENT OF SUPPORT
No commercial support has been provided for this activity.
3
Exam
1. The pH of the culture medium used for sperm washing can be maintained using one or more buffer
systems. Which of the following buffer systems is most commonly used for sperm preparation?
a. MOPS
b. HEPES
c. Calcium-magnesium free buffer
d. Saline
3. Which of the following sperm preparation methods guarantees removal of virus such as HIV or
hepatitis B from the washed sperm fraction?
a. Density-gradient centrifugation
b. Microfluidics
c. Glass-wool filtration
d. None of the above
4
6. Which of the following sperm-processing methods does not remove seminal leukocytes and reactive
oxygen species (ROS)?
a. Single-layer density-gradient centrifugation
b. Glass wool filtration
c. Hyaluronan-binding selection
d. Simple wash
7. Mature sperm will bind to which of the following substances used to coat a specially designed dish,
allowing easy pickup for ICSI?
a. Hyaluronidase
b. Platelet-activating factor (PAF)
c. Hyaluronan
d. Follicular fluid
10. A male partner provides a semen specimen on the day of egg retrieval with the following
parameters: 28 million sperm/mL; 40% motility; 8% normal morphology; some debris and >4 white
blood cells/high power field. What method is best for preparation of this ejaculate for IVF?
a. Density-gradient centrifugation followed by swim-up
b. Dextran gel column filtration followed by swim-up
c. Microfluidic quartz chamber
d. Simple-wash centrifugation
5
Welcome to the American Society for Reproductive
Preparation and Selection of Medicine’s eLearning modules. The subject of this
Sperm for IVF and ICSI presentation is Preparation and Selection of Sperm
for IVF and ICSI.
AMERICAN SOCIETY FOR
REPRODUCTIVE MEDICINE
6
The goal of any sperm preparation method is first to
Goals of Sperm Preparation Procedures remove sperm from inhibitory factors present in the
● Remove sperm from inhibitory effects of the seminal plasma. seminal plasma. Factors in seminal plasma inhibit
● Obtain sufficient viable and morphologically normal sperm for spermatozoa from undergoing capacitation and the
insemination of retrieved oocytes.
acrosome reaction and reduce the ability to
successfully fertilize an oocyte. In addition, it is
obvious that the ultimate goal of any sperm
preparation method is to obtain sufficient viable and
morphologically normal sperm for use in the selected
assisted reproductive technology (ART).
7
In summary, sperm isolation procedures should
Benefits of Sperm Isolation Techniques
remove or minimize viruses, bacteria, dead cells, and
● Removes or minimizes bacteria, viruses, antibodies, dead cells, leukocytes from the sperm, since exposure can be
leukocytes harmful to the sperm and to the oocytes. In doing so,
● Extends “shelf life” of sperm and promotes capacitation by
removal of seminal fluid components
such a procedure will extend the life of sperm, and
– Prostaglandins promote capacitation and the acrosome reaction.
– Oxygen radicals - reactive oxygen species (ROS) Finally, any sperm preparation procedure should
– Capacitation inhibitors
● Ability to resuspend sperm in a volume and concentration
result in a final volume of sperm fraction that is
appropriate for final use appropriate for the final use of the sperm: IVF, ICSI,
IUI.
Density Gradient
8
The simplest technique for preparing sperm is a
Simple Wash Overview
simple wash procedure, where the fresh semen,
• Simplest of the IUI sperm preparations to perform diluted with nutrient media is centrifuged, usually
• Removes seminal fluids and concentrates the sperm into a twice, and the supernatant removed. The final pellet
workable volume
of sperm is resuspended in a volume appropriate for
• Not recommended with high concentrations of dead sperm,
cellular contamination, or debris the end use of the sperm. A simple wash procedure
• Good choice for samples with borderline concentration is not recommended for specimens with high
• <20 million/mL in initial sample
concentrations of dead sperm or debris, since dead
sperm, cells, and debris would not be removed, and
would be pelleted with the live sperm. This technique
is advantageous for specimens clean of debris and
cells, and those with lower concentrations. A single
wash-centrifugation method is commonly used for
frozen-thawed sperm.
9
Advantages and disadvantages of the basic wash
Simple Wash
procedure are listed here. Advantages include that it
is easy and quick to perform, uses sterile plasticware
Advantages Disadvantages
● Simple and quick to perform ● Motile sperm concentrated in (centrifuge tubes, pipettes, media), and takes little
● High recovery of sperm presence of dead sperm, white
blood cells, and other seminal
time (30 minutes including all steps). This procedure
● Requires minimal processing of
sperm debris, which expose sperm to also results in a high recovery of sperm and requires
higher levels of reactive oxygen
species that may negatively affect minimal processing steps. However, with a simple
sperm function
● Usually not recommended alone wash, motile sperm are concentrated in the presence
for IVF (standard insemination)
of non-motile and dead sperm, white blood cells, and
other seminal debris. This exposes sperm to higher
levels of reactive oxygen species that may negatively
affect sperm function.
Image courtesy of Gianpiero Palermo, MD, PhD
10
The swim-up method is cost-effective and provides
Swim-up from Washed Sperm Pellet
for a very “clean,” highly motile final sample. It does,
however, take longer to perform than other
Advantages Disadvantages
● Cost-effective. ● Centrifugation of semen into a
preparations and the final concentrations may be
● Very “clean,” highly motile final pellet increases exposure of
motile healthy sperm to dead
low. A disadvantage of the swim-up from pellet
sample
cells and debris, ROS. technique is once again the problems with
● Not advantageous for specimens
with reduced motility and/or centrifuging raw semen into a pellet: motile, viable
concentration, or non-motile
sperm
sperm are centrifuged with dead sperm, cells and
● Takes longer time to perform debris, increasing the exposure of the “good” sperm
to oxygen radicals (ROS). The swim-up method also
takes longer to perform, and is not of benefit to
specimens with reduced motility and/or
ROS = reactive oxygen species
concentration.
11
The density-gradient preparation works best for
Density Gradient Overview
samples with a normal or high initial concentration of
● Best for samples with normal or high initial concentration of motile sperm, because only a percentage of the
motile sperm. motile sperm are recovered. It should be
– Only a percentage of the motile sperm are recovered.
recommended in all cases where white blood cells in
● Sperm filtered through layers of silane-coated silica particles
suspended in nutrient media. the semen sample exceed the normal baseline. In
● Sperm with good motility pass through the layer interfaces density-gradient preparations, sperm are filtered
leaving seminal fluid, non-motile cells, contamination, and
debris behind. through layers of silane-coated silica particles
● Pellet of motile sperm at the bottom of the centrifuge tube suspended in nutrient media. Sperm with good
can be recovered, washed free from gradient media, and used
for insemination.
motility pass through the layer interfaces leaving
– May be followed by swim-up from the pellet to further select seminal fluids, non-motile cells, contamination, and
for highly motile sperm and reduce concentration for oocyte
insemination.
debris in the interface between the gradient layers
and semen. The pellet of motile sperm at the bottom
of the centrifuge tube can be recovered, washed free
from the gradient media, and used for insemination.
For IVF, density-gradient centrifugation can be
followed by a swim-up to further select for a highly
motile and clean preparation.
12
The density-gradient preparation can be performed
Density Gradient: 1-layer Protocol
using one layer of gradient solution, usually 80% or
● Prepare gradient column 1. Pre-centrifugation 90%. The procedure is the same for all subsequent
– 1.5 mL of 90% gradient
media in a centrifuge tube John Doe
steps.
MRN: 585
Sperm pellet
13
Glass wool filtration results in a similar recovery of
Glass-Wool Filtration
motile sperm as in the density-gradient
centrifugation method, yielding an average of 50%-
Advantages Disadvantages
● Advantageous for ● Final product not as clean 70% progressively motile sperm. It is most successful
asthenozoospermic specimens or
those with sperm demonstrating
● Is not a commonly used for specimens with a high percentage of sluggishly
procedure
an abnormal hypoosmotic swelling ● Slightly more expensive and can motile sperm, or low total motility
(HOS) test 1,2
● Uses entire ejaculate
be time-consuming and difficult
to make the glass-wool column (asthenozoospermia), or where viability is low by the
● Separates sperm from urine in
cases of retrograde ejaculation3
● Initial centrifugation may result in hypoosmotic swelling (HOS) test. Glass-wool
increased ROS
● Eliminates leukocytes, and thus filtration also uses the entire ejaculate, thus
reduces ROS
● Yields significantly more increasing the probability of recovering more sperm,
chromatin condensed sperm than
swim-up and gradient
removes leukocytes, and effectively separates sperm
centrifugation 4 1
3
Remrev et al., 1989; 2 Borman et al., 2010;
Henkel et al., 2003; 4 Henkel et al., 1994
from urine following retrograde ejaculation.
However, glass-wool filtration results in a sperm
fraction that may not be as clean as other methods,
particularly with its risk of contamination with glass-
wool fibers. The set-up is more costly and time-
consuming to prepare the columns. All in all, glass-
wool filtration column filtration is not a commonly
used procedure for sperm preparation for ART.
14
The most common sperm preparation techniques are
Microfluidics
suboptimal for patients with severe oligozoospermia,
● Alternative to traditional sperm separation since many of these specimens exhibit not only low
procedures, especially for severe
oligozoospermic specimens1
sperm count but large amounts of cells and debris.
● First developed by Kricka and colleagues in Microfluidics has been proposed as an alternative to
19932
– Silicon and glass microfluidic devices traditional sperm separation methods, especially in
– Gravity-driven pumping system,
microscale integrated sperm sorter
Image courtesy of Charles
Bormann, Ph.D. suboptimal, oligozoospermic semen specimens.
(MISS)3 Kricka and colleagues in 1993 first developed
● Significant decrease in DNA fragmentation
as compared to initial semen, as well as microfluidic devices using silicon and glass devices for
following wash centrifugation, density-
gradient centrifugation, and swim-up4
sperm isolation. Such devices use a network of
● Quartz microfluidic system; highly motile branching microchannels that separate or
sperm within 5 minutes, used for ICSI5
1 Bormann et al., 2010; 2 Kricka et al., 1993; 3 Cho et al., 2003;
characterize sperm based upon motility and forward
progression. More recently, Cho and colleagues
4 Schulte et al., 2007; 5 Shibata et al., 2007
15
Patients may choose to use cryopreserved semen
Preparation of Cryopreserved Sperm for ART
samples for ART for many reasons, including use of
● Reasons for using cryopreserved sperm may include: donor sperm (which must be cryopreserved to
– Use of donor sperm comply with US Food and Drug Administration [FDA]
– Client depositors:
o Military duty or extended travel
regulations) or for those with military duty or
o Samples frozen prior to fertility-damaging treatments extended travel. Some have samples frozen prior to
Chemotherapy
Radiation
fertility-damaging treatments such as chemotherapy,
Vasectomy radiation and vasectomy. When working with
o Collection and storage of multiple samples to be combined for
increased concentration of available motile sperm cryopreserved samples, it is important to realize that
● Cryopreserved samples have a shorter lifespan and should be samples will inevitably have a lower number of motile
subjected to minimal handling during preparation
– Simple wash/centrifugation sperm than they do prior to freezing. As a result,
– Swim-up from thawed semen patients should be counseled on how many vials or
units of sperm to use based on post-thaw analysis.
Most often, patients will purchase at least 2 vials of
donor sperm, or request 2 vials of client depositor
semen for an ART cycle so that adequate numbers of
motile sperm can be recovered for insemination.
When preparing cryopreserved samples for ART,
minimal handling is best, as cryopreserved samples
are less robust than fresh samples. A single
centrifugation basic wash is typically adequate to
remove seminal fluids and cryoprotectants. It is also
important to dilute the thawed semen
cryopreservative slowly, so as to avoid osmotic shock
to the spermatozoa.
16
must be housed in impenetrable containers such as
cryogenic storage straws and/or stored in the vapor
phase of liquid nitrogen.
17
Sperm can be surgically retrieved from either the
Surgically Retrieved Sperm
epididymis—termed microepididymal sperm
● Epididymal sperm aspiration (MESA)—or retrieved directly from the
testicle, known as testicular sperm extraction (TESE).
It has been more than 20 years since reports of the
first ICSI procedure using sperm retrieved directly
Photo courtesy of Larry Lipshultz, MD
from the testicle. Not only has ICSI become a
standard procedure, but TESE has been routinely
● Testicular Sperm
used for males with obstructive and nonobstructive
azoospermia.
18
Often the biopsy tissue is examined in the operating
Surgically Retrieved Sperm for ART
room to determine the presence of sperm. The
● Examine for presence of sperm in surgeon will continue to biopsy different areas of the
the operating room testicle until sperm are found. However, sperm are
● Meticulous laboratory search of
mechanically processed testicular
not always identified in the operating room. A
tissue, possibly to include meticulous laboratory-based search of mechanically
enzymatic treatment
– Chance of finding sperm after
processed tissue, including enzymatic treatment, can
chemical digestion when sperm be performed to increase the chances of finding
were not initially found is 25%–30%1
– Other studies report a success rate sperm. Some studies have reported a 25%–30%
of 7% using mechanical preparation
followed by multi-hour, many-
chance of finding sperm following enzymatic
technician search in the laboratory. 1
Photo courtesy of Grace Centola, PhD
digestion, when sperm were not initially found after
1 Dabaja & Schlegel, 2013
mechanical manipulation. Additional studies have
reported a success rate of 7% when mechanical
preparation is followed by multi-hour, multi-
technician search for sperm.
19
Is fresh or frozen epididymal or testicular sperm
Fresh vs. Frozen Surgically Retrieved Sperm
better for ICSI?
● Motile, frozen-thawed epididymal sperm have ICSI outcomes Reports in the literature have generally concluded
comparable to fresh epididymal sperm. that there is no difference between fresh and frozen-
● No differences in fertilization rates or clinical and ongoing
pregnancy rates between fresh and frozen-thawed testicular
thawed sperm. However, with cryopreservation and
sperm. thawing, any motility is lost, and most centers prefer
– Significant decrease in implantation rates seen to work with motile sperm, since motility points to
– Sperm viability decreases following cryopreservation
viability and some sense of normalcy. Nonmotile
fresh testis sperm appear preferable for ICSI, since
viability rates approach 90% in fresh testis sperm. A
meta-analysis showed that fertilization rates, clinical
Shin & Turek, 2013
pregnancy rates, and ongoing clinical pregnancy rates
do not differ between the fresh and frozen groups.
However, a significant decrease in implantation rates
was observed with frozen-thawed testis sperm,
presumably due to the decreased viability following
thaw.
20
The standard method for determining sperm viability
Motility-stimulating Agents
has always been sperm motility. However, in cases
● Pentoxifylline where sperm are retrieved from the testis, sperm are
– Methylxanthine derivative most often immotile. Frequently, cryopreserved
– Most commonly used method for motility enhancement in sperm show decreased or no motility. Several
both fresh and frozen-thawed sperm
– 3–4 mM for 30 minutes
chemicals are known to enhance sperm motility,
● Caffeine most notably, pentoxyfylline and caffeine.
● Platelet-activating factor (PAF) Pentoxyfylline is a methylxanthine derivative that is
an inhibitor of phosphodiesterase, which then
increases intracellular levels of cyclic AMP (cAMP).
cAMP stimulates motility, velocity, and
hyperactivation of sperm, and has been shown to
enhance the acrosome reaction. Interestingly,
pentoxyfylline is approved by the FDA for treatment
of vascular disease. The stimulant effects of caffeine
can be used to improve or stimulate sperm motility.
Platelet-activating factor also improves motility, and
enhances sperm capacitation, the acrosome reaction
and oocyte penetration. The mechanism of action of
PAF is not completely understood and its use requires
further study.
21
The Sperm-Hyaluronan Binding Assay® (HBA) is a
Sperm-Hyaluronan Binding Assay® - HBA
commercially available sperm function test that
● Ability of mature, normal sperm with intact acrosome to bind determines the ability of the sperm to bind to a slide
to hyaluronic acid (HA), the main mucopolysaccharide of the coated with hyaluronic acid. Live, mature sperm will
cumulus
– Hyaluronic acid does not bind to immature sperm bind to the hyaluronic acid coating the plate. These
● Commercially available kit for testing and use sperm also have been shown to be normal and with
– PICSITM plate (Biocoat, Inc)
intact acrosome. Studies have shown that the HBA
– Hyaluron Binding Assay (HBA)
o FDA 510K approved test correlates with the level of sperm maturity, strict
● Rapid, simple test morphology, and chromatin integrity, as well as
● Correlation with sperm maturity, strict morphology,
chromosomal integrity, progressive motility, hemizona assay
results of the HZA, SPA, and fertilization in vitro.
(HZA), sperm penetration assay (SPA), and fertilization in vitro
22
Selection of Sperm Based on High-Magnification
A new approach for selection of morphologically
Morphology normal sperm using high magnification observation
● Motile sperm organelle morphology examination (MSOME) of unstained sperm was first reported in 2001 by
– Real-time, high magnification observation of sperm Bartoov, termed motile sperm organelle morphology
o >6000x magnification examination, or MSOME. Sperm can be visualized in
– Assesses 6 organelles: acrosome, post-acrosomal lamina,
neck, tail, mitochondria, and nucleus
real-time at magnifications of at least 6000x, which
– Selection of sperm free of nuclear vacuoles enables visualization of the sperm nucleus. MSOME
allows selection of sperm free of nuclear vacuoles,
● MSOME + ICSI = IMSI which are related to impairment of embryo
– Intracytoplasmic morphologically selected sperm injection
development. Together with micromanipulation
systems, MSOME has allowed a modified ICSI
Souza Setti et al., 2013; Bartoov et al., 2001
procedure termed IMSI, or intracytoplasmic
morphologically selected sperm injection.
23
maintain the media pH. HEPES buffer has a working
pH range of 6.8–8.2. The second most common
buffer is phosphate, such as that used in phosphate-
buffered saline where the pH is approximately 7.2–
7.4. The greatest advantage to these buffering
systems is that a carbon dioxide environment is not
needed. The processing and incubation of washed
sperm can be done in tightly closed tubes in ambient
air.
24
There are several methods of choice for sperm
Summary and Conclusions
preparation for assisted reproduction. These include
● There are multiple techniques for preparing sperm for assisted simple washing, density-gradient centrifugation,
reproduction, each of which has advantages and filtration, and swim-up. The method chosen should
disadvantages.
● The method for sperm processing should be chosen based on
be based on the quality of the sperm, specifically the
the sperm concentration and motility, whether it is fresh or sperm concentration and motility, whether the sperm
frozen, or ejaculated or surgically retrieved sperm.
are fresh or frozen, or whether ejaculated or
● Selecting the optimum sperm for ICSI can be done using
hypoosmotic swelling or MSOME/IMSI. Motility-enhancing surgically retrieved. Additionally, methods for sperm
chemicals can also be used to enhance sperm motility and selection include use of hypoosmotic swelling buffer
thus selection of viable sperm.
to choose viable sperm and high magnification
morphological assessment termed MSOME/IMSI.
Furthermore, motility-enhancing chemicals such as
pentoxyfylline, platelet-activating factor, or caffeine
can be used to improve or stimulate sperm motility
and allow for selection of motile and thus viable
sperm for assisted reproduction.
25
References
1. Bartoov B, Berkovitz A, Eltes F. Selection of spermatozoa with normal nuclei to improve the
pregnancy rate with intracytoplasmic sperm injection. N Engl J Med 345: 1067-1068, 2001.
2. Boitrelle F, Guthauser B, Alter L, Bailly M, Bergere M, Wainer R, Vialard F, Albert M, Selva J. High
magnification selection of spermatozoa prior to oocyte injection: confirmed and potential
indications. Reprod Biomed Online 28:6-13, 2014.
3. Bormann CL, Alagretti JR, Da Motta ELA, Serafini P, Smith GD. Preparation and selection of sperm for
IVF and ICSI. IN Reproductive Endocrinology and Infertility. Integrating Modern Clinical and
Laboratory Practice, DT Carrell and CM Peterson, eds., Springer, New York, 2010, pp. 579-590.
4. Cho BS, Schuster TG, Zhu X, Chang D, Smith GD, Takayama S. Passively driven integrated microfluidic
system for separation of motile sperm. Anal Chem 75:1671-1675.
5. Dabaja AA, Schlegel PN. Microdissection testicular sperm extraction: An update. Asian J. Androl
15:35-39, 2013.
6. Ebner T, Fillicori M, Tews G, Parmegiani L. A plea for a more physiological ICSI. Andrologia xx: 1-18,
2011.
7. Henkel RR, Franken DR, Lombard CJ, Schill W-B. Selective capacity of glass wool filtration for
chromatin condensed human spermatozoa: a possible therapeutic modality for male factor cases? J
Assis Reprod Genet 11: 395-400, 1994.
8. Huszar G, Sbracia M, Vigue L, Miller DJ, Shur BD. Sperm plasma membrane remodeling during
spermiogenic maturation in men: relationship among plasma membrane beta 1,4 galactosyl-
transferase, cytoplasmic creatine phosphokinase, and cratine phosphokinase isoform ratios. Biol
Reprod 56:1020-1024, 1997.
9. Knez K, Zorn B, Tomazevic T, Vrtacnik-Bokai E, Virant-Klun I. The IMSI procedure improves poor
embryo development in the same infertile couples with poor semen quality: A comparative
prospective randomized study. Reprod Biol Endocrin 9:123-130, 2011.
10. Kricka LJ, Nozaki O, Heyner S, Garside WT, Wilding P. Applications of a microfabricated device for
evaluating sperm function. Clin Chem 39:1944-1947, 1993.
11. Mehta A, Sigman M. Identification and preparation of sperm for ART. IN Current Management of
Male Infertility, Niederberger CS, Taneja SS. eds. Urologic Clinics of North America, Elsevier, New
York, 2014, pp. 169-180.
12. Mortimer D and Mortimer ST. Methods of sperm preparation for assisted reproduction. Ann Acad
Med Singapore 21:517-524, 1992.
13. Pagani RL, Serafini P, Srougi M. In-vitro fertilization and micromanipulation for male infertility. IN
Infertility in the Male, LI Lipshultz, SS Howards, CS Niederberger, eds. Cambridge University Press,
New York 2009, pp.500-515.
14. Rhemrev J, Jeyendran RS, Vermeiden JP, Zaneveld LJ. Human sperm selection by glass wool filtration
and two-layer discontinuous Percoll gradient centrifugation. Fertil Steril 52:685-690, 1989.
15. Schmidt-Sarosi C, Centola GM, Abeyawardene S, Sarosi P. Viable pregnancies after 24-hour
incubation of ejaculated sperm prior to ICSI. 63rd annual meeting, American Society for
Reproductive Medicine, Washington, D.C., October, 2007; P817.
26
16. Schulte RT, Chunga YK, Ohl DA, Takayama S, Smith GD. Microfluidic sperm sorting device provides a
novel method for selecting motile sperm with higher DNA integrity. Fertil Steril 88(Suppl 1): S76,
2007.
17. Schuster TG, Cho B, Keller LM, Takayama S, Smith GD. Isolation of motile spermatozoa from semen
samples using microfluidics. Reprod Biomed Online 7:75-81, 2003.
18. Setti AS, de Almeida Ferreira Braga, DP, Iaconelli A, Aoki T, Borges E. Twelve years of MSOME and
IMSI: A review. Repro BioMed Online 27:338-352, 2013.
19. Shibata D, Ando H, Iwase A, Harata T, Kikkawa F, Naruse K. Analysis of sperm motility and
fertilization rates after sperm separation by microfluidic sperm sorter made of quartz. Fertil Steril
88(Suppl 1):S110, 2007.
20. Shin DH and Turek PJ. Sperm retrieval techniques. Nature Reviews Urology 10:723-730, 2013.
21. Worrilow KC, Huynh HT, Bower JB, Anderson AR, Schillings W, Crain JL. PICSI vs ICSI: statistically
significant improvement in clinical outcomes in 240 in vitro fertilization (IVF) patients. Fertil Steril
88(Suppl 1):S37, 2007.
27